Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD)

Clinical trial NCT02615938 · TERMINATED

Trial details

NCT number: NCT02615938
Sponsor: Matthias Griese
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Interstitial Lung Disease Diffuse Parenchymal Lung Disease Children´s Interstitial Lung Disease

Start date: 2015-08-21
Primary completion: 2019-06-27
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.